Google Medical - Diagnostics and Research Profile - TipRanks - Google Analyst
4 Followers
Google Medical - Diagnostics and Research TipRanks - Google
AI Analyst
Success Rate
60 out of 114 ratings made a profit
Average Return
+6.00%
Average return per rating
Time Frame
Compare to
Copying Google Medical - Diagnostics and Research's trades since 2026 and holding each position for 1 Year would result in 52.63% of your transactions generating a profit, with an average return of 6.0% per rating.
Stock Rating Distribution
66.79% Hold
22.76% Buy
10.45% Sell
Distribution of Google Medical - Diagnostics and Research's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by Google Medical - Diagnostics and Research
Google Medical - Diagnostics and Research's Stock Coverage
Aspira Women's Health
Feb 04, 2026
Buy
Reiterated
$0.53
(115.10% Upside)
19Ratings
-50.00%
Hypha Labs
Feb 18, 2026
Sell
Downgraded
$0.03
(588.89% Upside)
4Ratings
―
0.00%
Aclaris Therapeutics
May 09, 2026
Hold
Reiterated
$5.50
(4.27% Upside)
36Ratings
―
0.00%
Lonza Group
May 20, 2026
Buy
Reiterated
$66.00
(-4.44% Downside)
32Ratings
-2.05%
VolitionRX
Jun 19, 2026
Hold
Upgraded
$1.50
(512.62% Upside)
46Ratings
-4.30%
Identa
Jun 23, 2026
Hold
Reiterated
$0.23
(-25.16% Downside)
26Ratings
-43.80%
Hudson Global
Jun 30, 2026
Hold
Reiterated
$11.00
(10.00% Upside)
34Ratings
―
0.00%
Tecan Group AG
Jul 02, 2026
Hold
Reiterated
CHF188.00
(-17.54% Downside)
11Ratings
―
0.00%
Circle8 Group
Jul 07, 2026
Hold
Upgraded
$0.73
(117.68% Upside)
46Ratings
+19.90%
Neuronetics
Jul 21, 2026
Hold
Reiterated
$1.50
(-46.14% Downside)
74Ratings
-35.80%
List of latest recommendations made by Google Medical - Diagnostics and Research. Click to expand and see Google Medical - Diagnostics and Research's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Google Medical - Diagnostics and Research activity FAQ
What is the performance of Google Medical - Diagnostics and Research's recommendations?
The percentage of profitable recommendations made by Google Medical - Diagnostics and Research is 53%, and the average return per transaction is 6.00%.
What stocks does Google Medical - Diagnostics and Research cover?
What was Google Medical - Diagnostics and Research's most profitable rating?
Google Medical - Diagnostics and Research’s most profitable ratings was a buy on CDNA stock on Apr 17, 2026 - Today. The return on the trade was +153.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here